| Similar Articles |
|---|
 |
The Motley Fool
February 7, 2008
Brian Orelli |
A Lab Match Made in Heaven The case of Thermo Electron and Fisher Scientific shows why mergers work.   |
The Motley Fool
May 8, 2006
Stephen D. Simpson |
Fisher Scientific Reels In a Deal A fair price and impressive market leverage give this merger between Fisher Scientific and Thermo Electron a better-than-average chance. Shareholders, take note. |
The Motley Fool
October 26, 2011
Tim Beyers |
Thermo Fisher Scientific Shares Plunged: What You Need to Know Shares of Thermo Fisher Scientific fell more than 10% in early trading and closed off almost that much after lowering full-year earnings and revenue guidance. |
The Motley Fool
May 2, 2006
Stephen D. Simpson |
Still Fishing for Value at Fisher At the right price, this would be an interesting play on health care and biomedical research. Investors, take note. |
Chemistry World
May 10, 2006
Katharine Sanderson |
Leading Lab Suppliers Merge Analytical instrument firm Thermo Electron and chemical manufacturer Fisher Scientific announced a merger, aiming to become the leading provider of laboratory products and services in the health sciences industry. |
The Motley Fool
August 16, 2007
Brian Orelli |
More Drugmaker Growth Without the FDA All that high-tech lab equipment has to come from somewhere. Here's how investors can benefit from it, too. |
Chemistry World
July 8, 2015
Phillip Broadwith |
Thermo Fisher to buy Alfa Aesar chemical supplies The acquisition complements its existing Fisher Scientific chemicals supply segment, and will be integrated with its laboratory products and services portfolio. |
CIO
July 27, 2012
Kim S. Nash |
How Thermo Fisher Mines Customer Feedback to Improve Service Thermo Fisher Scientific overhauled its customer feedback system to allow it to be more responsive to current customers and to take advantage of emerging markets |
The Motley Fool
November 9, 2005
Stephen D. Simpson |
Fishing for Value at Fisher Even with today's earnings-induced jump, there still might be some value here at researcher Fisher Scientific. Investors, take note. |
The Motley Fool
February 14, 2006
Stephen D. Simpson |
Looking for a Hook at Fisher Scientific Growth and market share are great, but return on invested capital tells the tale in the end. Investors, think twice before putting your money with this one. |
Chemistry World
April 19, 2013
Sarah Houlton |
Thermo Fisher to buy Life Technologies in $15.8bn deal Life Technologies specializes in research products, with a particular focus on genetic sequencing and DNA analysis. |
Bio-IT World
March 2007 |
Briefs Metabolomics Resources... LIMS Collaboration... Biomarker Collaboration... Analysis Update... |
The Motley Fool
May 25, 2007
Tom Taulli |
STARLIMS' Dim Reception The laboratory software developer's growth prospects weren't enough for IPO investors. |
Chemistry World
January 8, 2014
Phillip Broadwith |
Thermo Fisher to sell three analytical divisions to GE Healthcare GE will take over Thermo's cell culture supplies, gene modulation and magnetic beads businesses, which are expected to generate combined sales in the region of $250 million for 2013. |
The Motley Fool
February 7, 2008
Brian Orelli |
Invitrogen Integrates After a rough 2006 in which it struggled to integrate its acquisitions, Invitrogen used 2007 to show why it made all of its purchases. |
The Motley Fool
October 28, 2009
Brian Orelli |
The Waters Aren't Flowing. Yet. Not unlike its products that turn ugly mixtures into purer products, Waters turned an ugly top line into an acceptable earnings growth in the third quarter. |
The Motley Fool
January 6, 2009
Brian Orelli |
Boston Scientific Gets Gussied Up Boston Scientific is buying it's current partner, Ireland-based Labcoat. |
The Motley Fool
July 21, 2011
Seth Jayson |
Why the Future Looks Bright for Thermo Fisher Scientific Although Thermo Fisher Scientific shows inventory growth that outpaces revenue growth, the company may also display positive inventory divergence, suggesting that management sees increased demand on the horizon. |
The Motley Fool
May 10, 2006
Stephen D. Simpson |
A Test Maker Faces a Test of Its Own Beckman Coulter management seems to be tackling its challenges openly, but they're challenges nonetheless. Is the stock a buy? |
Military & Aerospace Electronics
August 2005
John McHale |
Thermo releases monitoring system for nuclear plants ViewPoint, a remote monitoring software platform, provides real-time personnel and area monitoring during routine and outage operations in the nuclear power industry. |
The Motley Fool
May 26, 2011
Andrew Tonner |
Does Agilent Technologies Deserve a Spot in Your Portfolio? Let's take a look at Agilent Technologies and some of its closest peers. |
Bio-IT World
July 15, 2003 |
The Technology Behind Best Practices One of the most interesting revelations of the 2003 Best Practices Awards was how many of the life science technologies born during the late 1990s appear to have matured. |
The Motley Fool
July 26, 2006
Ryan Fuhrmann |
Sigma-Aldrich's Steady Growth Growth at this life science company is steady, not spectacular. With a current stock price of $67.78, the shares trade at about 17 times projected earnings. |
CFO
January 10, 2007
Roy Harris |
The Year of Living Strategically While private-equity bids got lots of attention, some public-company mergers aimed to remake their industries in 2006. |
Chemistry World
May 18, 2015
Andy Extance |
$13.8bn Danaher bid wins Pall auction US-based conglomerate Danaher has agreed to acquire filtration, separation and purification provider Pall. |
BusinessWeek
January 22, 2007
Aaron Pressman |
Homeland Security 2.0 Five years after September 11, a new wave of smarter high-tech tools is coming to market. |
Bio-IT World
Dec 2005/Jan 2006 |
News Blast Medidata Contract... Thermo Deal... Enfinity & Beyond... Varian Grows... |
The Motley Fool
August 11, 2010
Charly Travers |
Insiders Are Buying Quidel. Should You? Does insider buying and a cheap price make for a good buy? |
Food Engineering
February 26, 2007 |
Industry & People Coffee Pacifica names vice president... Sweet Success Enterprises appoints senior vice president... National Food Laboratory adds services... etc. |
The Motley Fool
July 21, 2004 |
When "Pro Forma" Is Bad Forma Don't let a company you own fool you with "pro forma" numbers. They're gussied-up numbers that companies would prefer you focus on instead of less attractive numbers that are often more accurate representations of their health or performance. |
The Motley Fool
March 15, 2011
Cindy Johnson |
Dell Board Member Resigns: What Does She Know That You Don't? The positive read on the resignation is ... umm, don't see one. |
The Motley Fool
January 15, 2010
Selena Maranjian |
Warning: Your Mutual Fund Might Disappear Which could actually be a good thing. |
The Motley Fool
February 15, 2006
Stephen D. Simpson |
A Play on the Building Blocks of R&D Sigma-Aldrich might be suitable for those looking to play biological R&D without picking a specific pharma or biotech stock. |
The Motley Fool
February 3, 2011
Brian Orelli |
Add This Stock to Your Show-Me List Wait for the turnaround before investing in Boston Scientific; if it ever comes. |
The Motley Fool
November 3, 2004
Marko Djuranovic |
Scientific Games' Hot Hand Despite some debt concerns, this lottery machine maker looks solid. At its current valuation, Scientific Games offers investors a good opportunity to grab a piece of the growing gaming industry pie. |
Registered Rep.
November 1, 2006
Cheryl Winokur Munk |
The Heretic Kenneth Fisher, a global money manager and longtime Forbes columnist, is a proponent of the closed shop: He runs discretionary separate accounts for institutions and high-net-worth retail investors. Fisher farms out nothing. |
